1. Singapore Stocks

  2. •

    Health services

  3. •

    Hospital/Nursing management
Clearbridge Health Ltd.

Clearbridge Health Ltd.

SSGX:1H3
0.00
SGD
0.00
(0.00%)
9.90MMarket Cap
Feb 26Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
- -
- -
- -
0.01
0.02
0.03
0.01
0.01
0.01
0.01
- -
- -
Basic EPS, GAAP
0.01
0.01
- -
-0.01
-0.02
-0.01
- -
-0.02
-0.01
-0.03
-0.01
- -
- -
Free Cash Flow per Basic Share
- -
- -
-0.01
-0.02
-0.01
-0.01
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.02
0.04
0.04
0.07
0.05
0.05
0.05
0.05
0.04
0.01
- -
- -
0.01
Tangible Book Value per Share
0.02
0.04
0.04
0.06
0.03
0.01
0.03
0.02
0.02
- -
- -
- -
- -
Basic Weighted Avg Shares
866
866
866
577
877
940
1,076
1,111
1,112
1,114
687
3,290
1,113
Sales/Revenue/Turnover
- -
- -
- -
- -
6
22
36
11
16
10
10
10
- -
Operating Margin (%)
-1,413.89
-2,800.44
-6,069.92
-3,001.04
-184.5
-46.6
-11.62
-43.74
-8.66
-132.87
-37.47
-34.87
- -
Depreciation Expense
- -
- -
- -
- -
1
4
5
4
3
1
1
1
- -
Net Income, GAAP
5
5
-2
-7
-18
-11
1
-20
-11
-32
-4
-13
- -
Effective Tax Rate (%)
26.18
25.28
- -
- -
- -
- -
2.03
- -
- -
- -
- -
- -
- -
Profit Margin (%)
2,211.11
3,677.95
-1,586.18
-2,593.75
-300.7
-49.16
1.7
-174.53
-67.9
-309.4
-36.43
-130
- -
Working Capital
- -
2
1
27
5
5
11
14
6
4
-1
2
4
LT Debt
- -
1
- -
2
2
18
14
6
6
6
1
1
6
Total Equity
20
33
38
60
48
49
60
57
46
13
11
5
13
Return on Invested Capital (%)
- -
-10.01
- -
- -
- -
- -
-2.32
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
19.02
- -
- -
- -
- -
1.88
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
18.23
-5.5
-15.03
-33.97
-21.59
1.11
-35.45
-23.58
-122.64
-37.19
-203.89
- -

Capital Structure

SGD

•

in mil. unless spec.
Dec'19
Jun'20
Dec'23
ST Debt
6
5
2
LT Borrowings
17
14
4
LT Finance Leases
1
1
2
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,046
1,080
1,114
Market Capitalization
80
102
10

Working Capital

SGD

•

in mil. unless spec.
Dec'19
Jun'20
Dec'23
Total Current Assets
29
32
9
Cash, Cash Equivalents & STI
14
13
4
Accounts Receivable, Net
11
8
1
Inventories
2
1
- -
Total Current Liabilities
24
20
5
Payables & Accruals
- -
- -
- -
ST Debt
6
5
2
Deferred Revenue
- -
- -
- -

Growth Rates

SGD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-8.64%
-33%
-52.6%
Free Cash Flow
-33.94%
-68.31%
33.3%
Net Income, GAAP
-289.33%
-606.69%
257.76%
Sales/Revenue/Turnover
241.34%
-13.23%
0.26%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

SGD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
10
2024
- -
- -
10
2025
- -
5
10

Semi-annual Earnings Per Share

SGD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
-0.03
2024
- -
- -
-0.01
2025
- -
- -
- -

Semi-annual Dividends Per Share

SGD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Choon Yi Ong
Full Time Employees
115
Sector
Health services
Industry
Hospital/Nursing management
Address
37 Jalan Pemimpin Singapore CE Singapore 577177
IPO Date
Dec 18, 2017
Website
clearbridgehealth.com
Similar Companies
Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP)
Max Healthcare Institute Ltd (NSE:MAXHEALTH)
Fortis Healthcare Ltd. (NSE:FORTIS)
Bangkok Dusit Medical Services Public Co. Ltd. (SET:BDMS)
Yatharth Hospital and Trauma Care Services Limited (NSE:YATHARTH)
HCA Healthcare, Inc. (NYSE:HCA)
Business
Clearbridge Health Limited Clearbridge Health Limited (SGX:1H3.SI), an investment holding company founded in 2010 and headquartered at 37 Jalan Pemimpin, #08-05 Mapex, Singapore 577177, provides integrated healthcare solutions focused on precision medicine across Singapore, the Philippines, Hong Kong, Malaysia and internationally through its Strategic Investments, Healthcare Systems, and Medical Clinics/Centres segments. The company offers laboratory testing services; imaging services including general x-ray, computerized tomography scans, dental cone beam CT scans, mammography, magnetic resonance imaging and ultrasound; general health screening for diabetes, high blood pressure and high cholesterol; vaccination services; renal care and clinical services; aesthetics, dental and orthodontics treatments; healthcare organization consultancy; and wholesale of medicinal and pharmaceutical products. Clearbridge Health Limited operates an expanding network of medical clinics and centres while maintaining strategic equity investments in complementary precision medical technology firms; in 2025, it raised S$1.98 million through a private placement of 990 million new shares at S$0.002 each to investors including Asdew Acquisitions, Azure Capital and Ramesh Chandiramani, cleared all bank debts to become fully equity-financed, converted S$3.5 million in convertible bonds to equity, entered a binding term sheet on 28 April for the proposed US$330 million acquisition of pre-clinical biopharmaceutical innovator Elpis Biopharmaceuticals to advance oncology therapeutics and cellular therapies, and on 6 June formed a strategic alliance with Guangdong Amoreneg Medicine Research and Development Co. Ltd. (GAMRD) as consultant for establishing adult immune cellular banking facilities with new entities incorporated in Singapore and Hong Kong.